Aurinia Pharmaceuticals Stock Forecast

Buy candidate since Jun 04, 2026

The Aurinia Pharmaceuticals Inc stock price gained 4.47% on the last trading day (Thursday, 4th Jun 2026), rising from $15.67 to $16.37. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.66% from a day low at $15.62 to a day high of $16.66. The price has fallen in 6 of the last 10 days but is still up by 2.96% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 982 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $43.00 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.19% during the next 3 months and, with a 90% probability hold a price between $16.41 and $18.68 at the end of this 3-month period.

AUPH Signals & Forecast

The Aurinia Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $15.57 and $15.71. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 22, 2026, and so far it has fallen -0.305%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Aurinia Pharmaceuticals Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $15.54 and $15.14. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aurinia Pharmaceuticals Inc finds support just below today's level at $15.54. If this is broken, then the next support from accumulated volume will be at $15.14 and $14.37.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.04 (6.66%) between high and low. For the last week, the stock has had daily average volatility of 3.56%.

Our recommended stop-loss: $15.73 (-3.92%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 30 days ago.)

Trading Expectations (AUPH) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Aurinia Pharmaceuticals Inc to open at $16.22, and during the day (based on 14 day Average True Range), to move between $16.08 and $16.66, which gives a possible trading interval of +/-$0.571 (+/-3.55%) up or down from last closing price. If Aurinia Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 3.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $16.42 (0.31%) than the support at $15.54 (5.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aurinia Pharmaceuticals Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aurinia Pharmaceuticals Inc stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.643 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 5, 2026 - $16.22 ( 0.94%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk